APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antipyretic Medicine for Infants and Young Children

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antipyretic Medicine for Infants and Young Children Industry Growth and Trends Forecast to 2032

28 December 2025112 pages

Choose your research edition.

Industry ResearchAntipyretic Medicine for Infants and Young Children Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Antipyretic Medicine for Infants and Young Children Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Antipyretic Medicine for Infants and Young Children Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antipyretic Medicine for Infants and Young Children Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Antipyretic Medicine for Infants and Young Children Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

According to APO Research, the global Antipyretic Medicine for Infants and Young Children market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antipyretic Medicine for Infants and Young Children is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antipyretic Medicine for Infants and Young Children is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antipyretic Medicine for Infants and Young Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Antipyretic Medicine for Infants and Young Children market include Anqiu Lu'an, Atabay, Farmson, Granules Biocause, Granules India, IOLCP, Mallinckrodt, Novacyl and SKPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antipyretic Medicine for Infants and Young Children market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antipyretic Medicine for Infants and Young Children market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antipyretic Medicine for Infants and Young Children market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antipyretic Medicine for Infants and Young Children.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Antipyretic Medicine for Infants and Young Children market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antipyretic Medicine for Infants and Young Children Market by Company

Anqiu Lu'an

Atabay

Farmson

Granules Biocause

Granules India

IOLCP

Mallinckrodt

Novacyl

SKPL

Strides Shasun

Temad

Anhui BBCA Likang

Anhui Fubore

Hebei Jiheng

Xinhua Pharmaceutical

Zhejiang Kangle

Antipyretic Medicine for Infants and Young Children Segment by Type

Acetaminophen

Ibuprofen

Other

Antipyretic Medicine for Infants and Young Children Segment by Application

Online Sales

Offline Sales

Antipyretic Medicine for Infants and Young Children Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic Medicine for Infants and Young Children market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antipyretic Medicine for Infants and Young Children and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic Medicine for Infants and Young Children.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Antipyretic Medicine for Infants and Young Children companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Antipyretic Medicine for Infants and Young Children Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Antipyretic Medicine for Infants and Young Children Market Share by Region (2021-2026) Table 4. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Antipyretic Medicine for Infants and Young Children Market Share by Region (2027-2032) Table 6. Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Antipyretic Medicine for Infants and Young Children Market Size Share by Type (2021-2026) Table 9. Global Antipyretic Medicine for Infants and Young Children Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Antipyretic Medicine for Infants and Young Children Market Size Share Forecasted by Type (2027-2032) Table 11. North America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Antipyretic Medicine for Infants and Young Children Market Size Share by Application (2021-2026) Table 24. Global Antipyretic Medicine for Infants and Young Children Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Antipyretic Medicine for Infants and Young Children Market Size Share Forecasted by Application (2027-2032) Table 26. North America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Antipyretic Medicine for Infants and Young Children Industry Trends Table 37. Antipyretic Medicine for Infants and Young Children Industry Drivers Table 38. Antipyretic Medicine for Infants and Young Children Industry Opportunities and Challenges Table 39. Antipyretic Medicine for Infants and Young Children Industry Restraints Table 40. Global Antipyretic Medicine for Infants and Young Children Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Company (2021-2026) Table 42. Global Antipyretic Medicine for Infants and Young Children Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Antipyretic Medicine for Infants and Young Children Key Company Headquarters & Area Served Table 44. Global Antipyretic Medicine for Infants and Young Children Company, Product Type & Application Table 45. Global Antipyretic Medicine for Infants and Young Children Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Antipyretic Medicine for Infants and Young Children by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Anqiu Lu'an Company Information Table 49. Anqiu Lu'an Business Overview Table 50. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product Portfolio Table 52. Anqiu Lu'an Recent Development Table 53. Atabay Company Information Table 54. Atabay Business Overview Table 55. Atabay Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Atabay Antipyretic Medicine for Infants and Young Children Product Portfolio Table 57. Atabay Recent Development Table 58. Farmson Company Information Table 59. Farmson Business Overview Table 60. Farmson Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Farmson Antipyretic Medicine for Infants and Young Children Product Portfolio Table 62. Farmson Recent Development Table 63. Granules Biocause Company Information Table 64. Granules Biocause Business Overview Table 65. Granules Biocause Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Granules Biocause Antipyretic Medicine for Infants and Young Children Product Portfolio Table 67. Granules Biocause Recent Development Table 68. Granules India Company Information Table 69. Granules India Business Overview Table 70. Granules India Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Granules India Antipyretic Medicine for Infants and Young Children Product Portfolio Table 72. Granules India Recent Development Table 73. IOLCP Company Information Table 74. IOLCP Business Overview Table 75. IOLCP Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. IOLCP Antipyretic Medicine for Infants and Young Children Product Portfolio Table 77. IOLCP Recent Development Table 78. Mallinckrodt Company Information Table 79. Mallinckrodt Business Overview Table 80. Mallinckrodt Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Mallinckrodt Antipyretic Medicine for Infants and Young Children Product Portfolio Table 82. Mallinckrodt Recent Development Table 83. Novacyl Company Information Table 84. Novacyl Business Overview Table 85. Novacyl Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Novacyl Antipyretic Medicine for Infants and Young Children Product Portfolio Table 87. Novacyl Recent Development Table 88. SKPL Company Information Table 89. SKPL Business Overview Table 90. SKPL Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. SKPL Antipyretic Medicine for Infants and Young Children Product Portfolio Table 92. SKPL Recent Development Table 93. Strides Shasun Company Information Table 94. Strides Shasun Business Overview Table 95. Strides Shasun Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Strides Shasun Antipyretic Medicine for Infants and Young Children Product Portfolio Table 97. Strides Shasun Recent Development Table 98. Temad Company Information Table 99. Temad Business Overview Table 100. Temad Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Temad Antipyretic Medicine for Infants and Young Children Product Portfolio Table 102. Temad Recent Development Table 103. Anhui BBCA Likang Company Information Table 104. Anhui BBCA Likang Business Overview Table 105. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product Portfolio Table 107. Anhui BBCA Likang Recent Development Table 108. Anhui Fubore Company Information Table 109. Anhui Fubore Business Overview Table 110. Anhui Fubore Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Anhui Fubore Antipyretic Medicine for Infants and Young Children Product Portfolio Table 112. Anhui Fubore Recent Development Table 113. Hebei Jiheng Company Information Table 114. Hebei Jiheng Business Overview Table 115. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product Portfolio Table 117. Hebei Jiheng Recent Development Table 118. Xinhua Pharmaceutical Company Information Table 119. Xinhua Pharmaceutical Business Overview Table 120. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product Portfolio Table 122. Xinhua Pharmaceutical Recent Development Table 123. Zhejiang Kangle Company Information Table 124. Zhejiang Kangle Business Overview Table 125. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product Portfolio Table 127. Zhejiang Kangle Recent Development Table 128. North America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2026) Table 131. North America Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Antipyretic Medicine for Infants and Young Children Market Share Forecast by Country (2027-2032) Table 133. Europe Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2026) Table 136. Europe Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Antipyretic Medicine for Infants and Young Children Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2026) Table 141. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Share Forecast by Country (2027-2032) Table 143. Latin America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2026) Table 146. Latin America Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Antipyretic Medicine for Infants and Young Children Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2026) Table 151. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Antipyretic Medicine for Infants and Young Children Product Image Figure 3. Global Antipyretic Medicine for Infants and Young Children Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Antipyretic Medicine for Infants and Young Children Market Size (2021-2032) & (US$ Million) Figure 5. Global Antipyretic Medicine for Infants and Young Children Market Share by Region: 2025 VS 2032 Figure 6. Global Antipyretic Medicine for Infants and Young Children Market Share by Region (2021-2032) Figure 7. North America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Acetaminophen Image Figure 13. Global Acetaminophen Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Ibuprofen Image Figure 15. Global Ibuprofen Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Antipyretic Medicine for Infants and Young Children Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Antipyretic Medicine for Infants and Young Children Market Share by Type 2025 VS 2032 Figure 20. North America Antipyretic Medicine for Infants and Young Children Market Size Share by Type (2021-2032) Figure 21. Europe Antipyretic Medicine for Infants and Young Children Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Share by Type (2021-2032) Figure 23. Latin America Antipyretic Medicine for Infants and Young Children Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Antipyretic Medicine for Infants and Young Children Market Size Share by Type (2021-2032) Figure 25. Online Sales Image Figure 26. Global Online Sales Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Offline Sales Image Figure 28. Global Offline Sales Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Antipyretic Medicine for Infants and Young Children Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Antipyretic Medicine for Infants and Young Children Market Share by Application 2025 VS 2032 Figure 31. North America Antipyretic Medicine for Infants and Young Children Market Size Share by Application (2021-2032) Figure 32. Europe Antipyretic Medicine for Infants and Young Children Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Share by Application (2021-2032) Figure 34. Latin America Antipyretic Medicine for Infants and Young Children Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Antipyretic Medicine for Infants and Young Children Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Antipyretic Medicine for Infants and Young Children Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Antipyretic Medicine for Infants and Young Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Antipyretic Medicine for Infants and Young Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032) Figure 41. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Antipyretic Medicine for Infants and Young Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032) Figure 44. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032) Figure 47. Latin America Antipyretic Medicine for Infants and Young Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Antipyretic Medicine for Infants and Young Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032) Figure 50. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Acetaminophen
  • Ibuprofen
  • Other
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Anqiu Lu'an
  • Atabay
  • Farmson
  • Granules Biocause
  • Granules India
  • IOLCP
  • Mallinckrodt
  • Novacyl
  • SKPL
  • Strides Shasun
  • Temad
  • Anhui BBCA Likang
  • Anhui Fubore
  • Hebei Jiheng
  • Xinhua Pharmaceutical
  • Zhejiang Kangle

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Antipyretic Medicine for Infants and Young Children Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2032)
  5. 1.4.1 Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2021-2026)
  6. 1.4.2 Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2027-2032)
  7. 1.5 Key Regions Antipyretic Medicine for Infants and Young Children Market Size (2021-2032)
  8. 1.5.1 North America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (2021-2032)
2 Antipyretic Medicine for Infants and Young Children Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Acetaminophen
  3. 2.1.2 Ibuprofen
  4. 2.1.3 Other
  5. 2.2 Global Antipyretic Medicine for Infants and Young Children Market Size by Type
  6. 2.2.1 Global Antipyretic Medicine for Infants and Young Children Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Antipyretic Medicine for Infants and Young Children Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Antipyretic Medicine for Infants and Young Children Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Antipyretic Medicine for Infants and Young Children Market Size by Regions
  10. 2.3.1 North America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Type (2021-2026)
3 Antipyretic Medicine for Infants and Young Children Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Online Sales
  3. 3.1.2 Offline Sales
  4. 3.2 Global Antipyretic Medicine for Infants and Young Children Market Size by Application
  5. 3.2.1 Global Antipyretic Medicine for Infants and Young Children Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Antipyretic Medicine for Infants and Young Children Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Antipyretic Medicine for Infants and Young Children Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Antipyretic Medicine for Infants and Young Children Market Size by Regions
  9. 3.3.1 North America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Antipyretic Medicine for Infants and Young Children Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Antipyretic Medicine for Infants and Young Children Industry Trends
  2. 4.2 Antipyretic Medicine for Infants and Young Children Industry Drivers
  3. 4.3 Antipyretic Medicine for Infants and Young Children Industry Opportunities and Challenges
  4. 4.4 Antipyretic Medicine for Infants and Young Children Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Antipyretic Medicine for Infants and Young Children Revenue (2021-2026)
  2. 5.2 Global Antipyretic Medicine for Infants and Young Children Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Antipyretic Medicine for Infants and Young Children Key Company Headquarters & Area Served
  4. 5.4 Global Antipyretic Medicine for Infants and Young Children Company, Product Type & Application
  5. 5.5 Global Antipyretic Medicine for Infants and Young Children Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Antipyretic Medicine for Infants and Young Children Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Antipyretic Medicine for Infants and Young Children Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Antipyretic Medicine for Infants and Young Children Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Anqiu Lu'an
  2. 6.1.1 Anqiu Lu'an Company Information
  3. 6.1.2 Anqiu Lu'an Business Overview
  4. 6.1.3 Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product Portfolio
  6. 6.1.5 Anqiu Lu'an Recent Developments
  7. 6.2 Atabay
  8. 6.2.1 Atabay Company Information
  9. 6.2.2 Atabay Business Overview
  10. 6.2.3 Atabay Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Atabay Antipyretic Medicine for Infants and Young Children Product Portfolio
  12. 6.2.5 Atabay Recent Developments
  13. 6.3 Farmson
  14. 6.3.1 Farmson Company Information
  15. 6.3.2 Farmson Business Overview
  16. 6.3.3 Farmson Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Farmson Antipyretic Medicine for Infants and Young Children Product Portfolio
  18. 6.3.5 Farmson Recent Developments
  19. 6.4 Granules Biocause
  20. 6.4.1 Granules Biocause Company Information
  21. 6.4.2 Granules Biocause Business Overview
  22. 6.4.3 Granules Biocause Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Granules Biocause Antipyretic Medicine for Infants and Young Children Product Portfolio
  24. 6.4.5 Granules Biocause Recent Developments
  25. 6.5 Granules India
  26. 6.5.1 Granules India Company Information
  27. 6.5.2 Granules India Business Overview
  28. 6.5.3 Granules India Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Granules India Antipyretic Medicine for Infants and Young Children Product Portfolio
  30. 6.5.5 Granules India Recent Developments
  31. 6.6 IOLCP
  32. 6.6.1 IOLCP Company Information
  33. 6.6.2 IOLCP Business Overview
  34. 6.6.3 IOLCP Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 IOLCP Antipyretic Medicine for Infants and Young Children Product Portfolio
  36. 6.6.5 IOLCP Recent Developments
  37. 6.7 Mallinckrodt
  38. 6.7.1 Mallinckrodt Company Information
  39. 6.7.2 Mallinckrodt Business Overview
  40. 6.7.3 Mallinckrodt Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Mallinckrodt Antipyretic Medicine for Infants and Young Children Product Portfolio
  42. 6.7.5 Mallinckrodt Recent Developments
  43. 6.8 Novacyl
  44. 6.8.1 Novacyl Company Information
  45. 6.8.2 Novacyl Business Overview
  46. 6.8.3 Novacyl Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Novacyl Antipyretic Medicine for Infants and Young Children Product Portfolio
  48. 6.8.5 Novacyl Recent Developments
  49. 6.9 SKPL
  50. 6.9.1 SKPL Company Information
  51. 6.9.2 SKPL Business Overview
  52. 6.9.3 SKPL Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 SKPL Antipyretic Medicine for Infants and Young Children Product Portfolio
  54. 6.9.5 SKPL Recent Developments
  55. 6.10 Strides Shasun
  56. 6.10.1 Strides Shasun Company Information
  57. 6.10.2 Strides Shasun Business Overview
  58. 6.10.3 Strides Shasun Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Strides Shasun Antipyretic Medicine for Infants and Young Children Product Portfolio
  60. 6.10.5 Strides Shasun Recent Developments
  61. 6.11 Temad
  62. 6.11.1 Temad Company Information
  63. 6.11.2 Temad Business Overview
  64. 6.11.3 Temad Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Temad Antipyretic Medicine for Infants and Young Children Product Portfolio
  66. 6.11.5 Temad Recent Developments
  67. 6.12 Anhui BBCA Likang
  68. 6.12.1 Anhui BBCA Likang Company Information
  69. 6.12.2 Anhui BBCA Likang Business Overview
  70. 6.12.3 Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product Portfolio
  72. 6.12.5 Anhui BBCA Likang Recent Developments
  73. 6.13 Anhui Fubore
  74. 6.13.1 Anhui Fubore Company Information
  75. 6.13.2 Anhui Fubore Business Overview
  76. 6.13.3 Anhui Fubore Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Anhui Fubore Antipyretic Medicine for Infants and Young Children Product Portfolio
  78. 6.13.5 Anhui Fubore Recent Developments
  79. 6.14 Hebei Jiheng
  80. 6.14.1 Hebei Jiheng Company Information
  81. 6.14.2 Hebei Jiheng Business Overview
  82. 6.14.3 Hebei Jiheng Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product Portfolio
  84. 6.14.5 Hebei Jiheng Recent Developments
  85. 6.15 Xinhua Pharmaceutical
  86. 6.15.1 Xinhua Pharmaceutical Company Information
  87. 6.15.2 Xinhua Pharmaceutical Business Overview
  88. 6.15.3 Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product Portfolio
  90. 6.15.5 Xinhua Pharmaceutical Recent Developments
  91. 6.16 Zhejiang Kangle
  92. 6.16.1 Zhejiang Kangle Company Information
  93. 6.16.2 Zhejiang Kangle Business Overview
  94. 6.16.3 Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product Portfolio
  96. 6.16.5 Zhejiang Kangle Recent Developments
7 North America
  1. 7.1 North America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
  3. 7.3 North America Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
  3. 8.3 Europe Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
  3. 10.3 South America Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst